Can low DHEA-S together with high SHBG produce a functional androgen deficiency?

In a 43-year-old female, the biochemical pattern of low dehydroepiandrosterone sulfate (DHEA-S) combined with high sex hormone-binding globulin (SHBG) creates a dual-pronged reduction in androgen activity. This state is often characterized as a "functional" androgen deficiency because it compromises the biological availability and cellular action of testosterone, even when total hormone levels might appear within a broad reference range.

Clinical and effectiveness evidence

The clinical impact of this pattern is significant for female health, particularly regarding libido, energy levels, and overall well-being.

• Androgen Deficit Symptoms: This specific hormonal profile is frequently associated with Hypoactive Sexual Desire Disorder (HSDD) and fatigue. Research indicates that women with low DHEA-S often report lower scores on validated sexual function scales.
• Total vs. Bioavailable Testosterone: In women, total testosterone levels can be misleading. A study of premenopausal women demonstrated that while total testosterone might remain stable, high SHBG levels significantly reduce the "Free Androgen Index" (FAI), which is a more accurate predictor of androgenic symptoms than total testosterone alone.
• Age-Related Decline: In women in their 40s, DHEA-S levels have typically declined by approximately 50-70% from their peak in the mid-20s, making this demographic particularly susceptible to precursor-limited androgen deficiency.

Mechanistic explanations

The functional deficiency is driven by two distinct but compounding physiological mechanisms:

• Precursor Limitation: DHEA-S is the most abundant circulating steroid and the primary reservoir for androgen production in women. It is converted into DHEA via enzymatic hydrolysis and then transformed by enzymes like 3β-hydroxysteroid dehydrogenase (3βHSD) and 17β-hydroxysteroid dehydrogenase (17βHSD) into androstenedione and testosterone. Low DHEA-S levels directly limit the substrate available for this intracrine production, which accounts for nearly 50% of the total female androgen pool.
• Bioavailability Sequestration: SHBG is the high-affinity transport protein for testosterone. According to the "free hormone hypothesis," only the unbound (free) fraction—typically 1–2% of total testosterone—can diffuse into cells to activate androgen receptors. High SHBG levels increase the bound fraction, sequestering testosterone in the bloodstream and preventing it from exerting physiological effects at the tissue level. Genetic studies (ρG = -0.60) and clinical interventions confirm this strong inverse relationship between SHBG and testosterone bioavailability.

Bottom line

The combination of low DHEA-S and high SHBG results in a functional androgen deficiency by simultaneously restricting the "raw materials" (precursors) needed for testosterone synthesis and "locking away" the available testosterone in the blood. For a 43-year-old woman, this pattern provides a scientifically sound explanation for symptoms of androgen deprivation despite potentially normal total testosterone levels.